[ad_1] The 2019 coronavirus disease (COVID-19) pandemic continues to spread around the world, causing over 59.17 million confirmed infections and over 1.39 million deaths. The causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in Wuhan, China in December 2019. Understanding the size of the virus and its prevalence …
Read More »
[ad_1] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which causes COVID-19 (coronavirus disease 2019) has infected over 58.5 million people worldwide and killed over 1.38 million is one of the health crises most significant global in recent memory. There are currently no effective and safe vaccines to prevent SARS CoV-2 …
Read More »
[ad_1] A study conducted at the United States Army Research Institute of Infectious Diseases shows how a relatively simple full-length DNA vaccine against the spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can elicit a neutralizing antibody response in a animal model – even after a single shot …
Read More »
[ad_1] Belgian and German researchers have shown how the glycoprotein peak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is fine-tuned based on human airway temperature and protease conditions, which in turn improves viral transmission and the consequent pathology. Their study is available on bioRxiv * prepress server. The rapid …
Read More »
[ad_1] Most vaccine research in the current 2019 coronavirus (COVID-19) pandemic has focused on the role of the angiotensin converting enzyme 2 (ACE2) receptor in mediating viral entry into the host cell. However, a recent study published on the prepress server bioRxiv* in November 2020 discovers the major role played …
Read More »